SCHEMBL9047230

SCHEMBL9047230

O=[N+]([O-])c1cccc(-c2c(Cl)ncnc2Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
TDP1 Q9NUW8 1/20 0.51
LMNA P02545 3/20 0.50
TSHR P16473 1/20 0.50
GRIN2D O15399 1/20 0.49
GRIN3B O60391 1/20 0.49
GRIN1 Q05586 1/20 0.49
GRIN2A Q12879 1/20 0.49
GRIN2B Q13224 1/20 0.49
GRIN2C Q14957 1/20 0.49
GRIN3A Q8TCU5 1/20 0.49
ATM Q13315 1/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MAPT P10636 2/20 0.48
PIK3CD O00329 1/20 0.47
PIK3CA P42336 1/20 0.47
PIK3CB P42338 1/20 0.47
PIK3CG P48736 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9044674 0.80 ADK (0.50) ALDH1A1TDP1LMNANPC1RAB9A
SCHEMBL5418627 0.80 ALDH1A1 (0.58) ALDH1A1TDP1LMNATSHRGRIN2D
SCHEMBL9045069 0.79 KDM1A (0.50) ALDH1A1PIK3CD
SCHEMBL29813608 0.78 NPC1 (0.52) ALDH1A1TDP1LMNATSHRATM
SCHEMBL4427261 0.78 NPC1 (0.52) ALDH1A1TDP1LMNATSHRATM
SCHEMBL4904156 0.78 PDE4D (0.47) ALDH1A1TDP1LMNATSHRATM
SCHEMBL3075732 0.77 CYP1A2 (0.57) ALDH1A1TDP1LMNATSHRATM
SCHEMBL4775239 0.77 CSF1R (0.54) ALDH1A1TDP1LMNAGRIN2DGRIN3B
SCHEMBL5357782 0.77 GABRP (0.54) ALDH1A1TDP1NPC1RAB9ASMN1; SMN2
SCHEMBL6738366 0.76 TSHR (0.76) ALDH1A1TDP1LMNATSHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0510526-B1 Use of sulfonamides as drug and new sulfonamides HOFFMANN LA ROCHE (CH) 1996-12-04 EP disclosed
US-5270313-A Treatment of circulatory disorders HOFFMANN-LA ROCHE INC. (US) 1993-12-14 US disclosed
EP-0510526-A1 Use of sulfonamides as drug and new sulfonamides F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1992-10-28 EP disclosed